TY  - JOUR

T1  - CALIBER - A phase II randomised feasibility trial of chemoablation with mitomycin versus surgical management in low risk non-muscle invasive bladder cancer

JO  - BJU International

UR  - http://eprints.whiterose.ac.uk/158343/

PY  - 2020/03/03

AU  - Mostafid AH

AU  - Porta N

AU  - Cresswell J

AU  - Griffiths TRL

AU  - Kelly JD

AU  - Penegar SR

AU  - Davenport K

AU  - McGrath JS

AU  - Campain N

AU  - Cooke P

AU  - Masood S et al

ED  - 

DO  - DOI: 10.1111/bju.15038

PB  - Wiley

Y2  - 2024/12/22

ER  -